Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
Add more filters










Publication year range
1.
Otolaryngol Pol ; 61(5): 744-9, 2007.
Article in Polish | MEDLINE | ID: mdl-18552011

ABSTRACT

Post-irradiation sarcomas of head and neck appear seldom, and among them leiomyosarcoma (LMS) is exceptionally rare. 11 cases of this tumour, associated with previous irradiation and situated in this anatomical area have been described so far. The aim of this study was to describe 56 year-old patient with LMS and to compare this case with the others described in the literature. What brought our attention were scanty clinical symptoms coexisted with extensive radiological changes. Radiotherapy can give rise to the development of LMS in different moments of time after the treatment of primary tumor has been finished. In this aspect patients who undergone radiotherapy in the early stage of live and who are more susceptible to this kind of treatment should be followed up more closely and carefully.


Subject(s)
Leiomyosarcoma/pathology , Maxillary Sinus Neoplasms/pathology , Neoplasms, Radiation-Induced/pathology , Humans , Male , Middle Aged
2.
J Neurooncol ; 80(3): 243-9, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16710745

ABSTRACT

There is a lot of data suggesting that modifications of cell glycoconjugates may be important in progression of cancer. In the present work we studied activities of lysosomal exoglycosidases: beta-hexosaminidase and its isoenzymes A and B, beta-galactosidase and alpha-mannosidase, in human gliomas. Enzyme activity was determined spectrophotometrically based on the release of p-nitrophenol from p-nitrophenyl-derivative of appropriate sugars. The activities of the exoglycosidases tested were significantly higher in malignant glial tumors than in control tissue (normal brain tissue) and non-glial tumors. The highest activities of exoglycosidases were observed in high-grade gliomas, and a positive correlation of enzyme activities and degree of malignancy was noted. Our results suggest that lysosomal exoglycosidases may participate in the progression and dynamical development of glial tumors.


Subject(s)
Brain Neoplasms/enzymology , Glioma/enzymology , alpha-Mannosidase/metabolism , beta-Galactosidase/metabolism , beta-N-Acetylhexosaminidases/metabolism , Brain Neoplasms/pathology , Disease Progression , Gene Expression Regulation, Neoplastic , Glioma/pathology , Glycoside Hydrolases/metabolism , Humans , Isoenzymes/metabolism
3.
Rocz Akad Med Bialymst ; 49 Suppl 1: 242-3, 2004.
Article in English | MEDLINE | ID: mdl-15638437

ABSTRACT

Gliomas are the most common neoplastic tumours of the central nervous system. The aim of the study was to evaluate the proliferative activity of chosen types of gliomas and to analyse their correlation with histological type, malignancy grade, location, size and clinical symptoms. The study involved patients with astrocytoma, anaplastic astrocytoma, glioblastoma, oligodendroglioma, anaplastic oligodendroglioma. The proliferative activity (the labelling index--LI) of glial cells was estimated, using immunohistochemistry. In studied groups, a positive correlation was noted between the proliferative activity and tumour size, but not between the proliferative activity and tumour location. The clinical symptoms were conditioned mainly by tumour location and, to a smaller extent, by its size.


Subject(s)
Brain Neoplasms/pathology , Cell Division/physiology , Adolescent , Adult , Aged , Astrocytoma/pathology , Brain Neoplasms/surgery , Female , Glioblastoma/pathology , Humans , Male , Middle Aged , Oligodendroglioma/pathology
4.
Rocz Akad Med Bialymst ; 49 Suppl 1: 16-8, 2004.
Article in English | MEDLINE | ID: mdl-15638361

ABSTRACT

Gliomas cause a therapeutic problem because of their localization and asymptomatic growth in the initial phase. Neoplastic growth is connected with disturbance between proliferation and apoptosis. In the study, we assessed the Bcl-2 family proteins involved in apoptosis in gliomas. The study comprised 61 patients with gliomas and based on tissue material sent for the diagnosis. Apoptosis was assessed in various types of gliomas and was defined by the apoptotic index (IA) and shown immunohistochemically with using Bcl-2, Bax and Bcl-x antibodies. The data were statistically analyzed. We found an increased percentage of the Bax (+) cells in less matured gliomas. A reverse dependence was revealed for Bcl-x. It was found that, probably in gliomas, the assessment of the Bcl-2 family proteins may serve only as an additional parameter for the evaluation of the disease course and the therapeutic success.


Subject(s)
Apoptosis , Astrocytoma/pathology , Brain Neoplasms/pathology , Glioblastoma/pathology , Oligodendroglioma/pathology , Humans , Proto-Oncogene Proteins c-bcl-2/analysis , bcl-2-Associated X Protein
5.
Rocz Akad Med Bialymst ; 49 Suppl 1: 49-51, 2004.
Article in English | MEDLINE | ID: mdl-15638372

ABSTRACT

Not only bile but also chronic cholecystitis may play a role in gallbladder carcinogenesis. Numerous studies have revealed a close correlation between chronic inflammation and neoplasia. The experiments were conducted on paraffin sections, obtained from 377 surgically resected gallbladders with chronic cholecystitis. Immunohistochemical reaction was conducted on deparaffinized sections, using a monoclonal antibody against 8-hydroxydeoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage. An increase was found in the expression of 8-hydroxydeoxyguanosine in chronic cholecystitis. The level of 8-OhdG expression is associated with inflammation intensity and disease duration. DNA damage, observed in chronic cholecystitis, indicates a correlation between chronic inflammation and gallbladder carcinogenesis.


Subject(s)
Cholecystitis/complications , Gallbladder Neoplasms/epidemiology , Adolescent , Adult , Child , Child, Preschool , Cholecystitis/pathology , Cholecystitis/surgery , Female , Gallbladder Neoplasms/pathology , Humans , Infant , Male , Middle Aged
6.
Neurol Neurochir Pol ; 35 Suppl 5: 90-100, 2001.
Article in Polish | MEDLINE | ID: mdl-11935688

ABSTRACT

UNLABELLED: MR proton spectroscopy (1H MRS) has been widely applied in characterisation and differentiation of brain tumors, staging, recurrence of pathologic process, post radiotherapy changes and other lesions mimicking neoplasm like abscesses. Despite of many studies performed over last 3 years in many countries spectroscopic pattern (phenotype) of brain tumors is still not well estimated and the role of each metabolite as an indicator of histopathologic grade and type of the tumor is still unknown. MATERIALS AND METHODS: In vivo 1H MR spectroscopy was prospectively performed in 36 patients with intracranial tumors (low grade gliomas, high grade gliomas, meningiomas and abscesses). Examinations was performed with 1.5 T system, using voxels of 8 cc. RESULTS: In high grade gliomas level of NAA was decreased, and consequently low ratios of NAA to other metabolites were obtained; lactate and choline peaks were markedly increased. In patients with meningiomas signal of NAA was reduced, while in abscesses group peaks of acetate and succinate were observed. Authors analysed ratios of metabolites in above-mentioned tumors. The method is especially useful in differential diagnosis in neoplastic and nonneoplastic cases. CONCLUSIONS: Our study confirms diagnostic value of 1H MRS in doubtful cases of intracranial tumors.


Subject(s)
Brain Abscess/diagnosis , Brain Neoplasms/diagnosis , Magnetic Resonance Spectroscopy , Brain Abscess/pathology , Brain Neoplasms/pathology , Case-Control Studies , Diagnosis, Differential , Glioma/diagnosis , Humans , Meningeal Neoplasms/diagnosis , Meningioma/diagnosis , Prospective Studies , Protons , Sensitivity and Specificity
7.
Folia Histochem Cytobiol ; 39 Suppl 2: 205-6, 2001.
Article in English | MEDLINE | ID: mdl-11820610

ABSTRACT

MIB-I is a proliferative activity marker of multiform glioblastomas which are the most frequent tumors of the central nervous system. They are characterizad by differential rate and prognosis. The aim of the study was to determine the proliferative activity of multiform glioblastomas and estimation of the correlation between tumors' proliferative activity and tumors' localization, size, patients' age and sex. 24 patients (18 females and 6 males) with multiform glioblastomas were analyzed. The mean patients' age was 52.1. The proliferative activity was calculated as a proliferation index: IP for MIB-I. Cells with positive reaction were determined by MIB-I which was compared to all neoplastic cells. The most frequent localization of the tumors were frontal and temporal lobes of the brain. The size of the tumors ranged from 2.5 to 5.3 cm (mean 3.9). Mean IP was 43.2 (SD+/-17.4). We found no correlation between IP MIB-I and localization of the tumor, patients' age and sex. There was a marginal statistically significant correlation between IP MIB-I and size of the tumor (p=0.005).


Subject(s)
Biomarkers, Tumor/analysis , Brain Neoplasms/chemistry , Brain Neoplasms/pathology , Glioblastoma/chemistry , Glioblastoma/pathology , Nuclear Proteins/analysis , Antigens, Nuclear , Cell Division , Female , Humans , Male , Predictive Value of Tests , Prognosis
8.
Thromb Haemost ; 86(6): 1416-20, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11776308

ABSTRACT

Blood coagulation is activated commonly in pancreatic carcinoma but the role of the tumor cell in this activation is undefined. Immunohistochemical procedures were applied to fixed sections of 22 cases of resected adenocarcinoma of the pancreas to determine the presence of components of coagulation and fibrinolysis pathways in situ. Tumor cell bodies stained for tissue factor: prothrombin: and factors VII, VIIIc, IX, X, XII, and subunit "a" of factor XIII. Fibrinogen existed throughout the tumor stroma, and tumor cells were surrounded by fibrin. Staining for tissue factor pathway inhibitor, and plasminogen activators was minimal and inconsistent. Plasminogen activator inhibitors -1, -2, and -3 were present in the tumor stroma, and on tumor cells and vascular endothelium. Extravascular coagulation activation exists associated with pancreatic carcinoma cells in situ that is apparently unopposed by naturally occurring inhibitors or the plasminogen activator-plasmin system. We postulate that such local coagulation activation may regulate growth of this malignancy. These findings provide a rationale for testing agents that modulate the blood coagulation/fibrinolytic system (that inhibit tumor growth in other settings) in pancreatic carcinoma.


Subject(s)
Adenocarcinoma/chemistry , Blood Coagulation Factors/analysis , Neoplasm Proteins/analysis , Pancreatic Neoplasms/chemistry , Adenocarcinoma/blood , Adenocarcinoma/complications , Aged , Endothelium, Vascular/chemistry , Female , Fibrin/analysis , Fibrinogen/analysis , Humans , Immunoenzyme Techniques , Male , Middle Aged , Neoplastic Stem Cells/chemistry , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/complications , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activator Inhibitor 2/analysis , Protein C/analysis , Protein S/analysis , Prothrombin/analysis , Stromal Cells/chemistry , Thrombophilia/etiology , Thromboplastin/analysis
9.
Exp Toxicol Pathol ; 52(5): 455-63, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11089897

ABSTRACT

The aim of the study was to examine the process of sciatic nerve regeneration and changes in the dorsal root ganglia (from which sensory fibres of the sciatic nerve extend) in animals intoxicated with ethanol. The experiment used 20 rats, divided into two groups: control and treated. The treated animals were intragastrically given 2g/kg b.w. of ethanol in 25% aqueous solution. In both groups the right sciatic nerve was transected and then sutured. After 5 months the animals were anaesthetized. The left and the right spinal dorsal ganglia-L5 and sections from the non-operated and operated sciatic nerves were collected for analysis. Ultrastructural examinations and morphometric measurements were conducted. It was found that ethanol administrated to rats inhibited regeneration of the transected and then sutured sciatic nerve, impairing the growth of axons in the transected nerve and destroying the regenerating sensory ganglion cells. The mechanism of the changes described may be associated with axonal transport disorders or with the suppressed production of biologically active substances, which affect nerve regeneration.


Subject(s)
Ethanol/poisoning , Nerve Regeneration/drug effects , Sciatic Nerve/pathology , Animals , Male , Neurons/pathology , Neurons/ultrastructure , Rats , Rats, Wistar , Sciatic Nerve/physiology , Sciatic Nerve/ultrastructure , Spinal Nerve Roots/pathology , Spinal Nerve Roots/ultrastructure
10.
Thromb Res ; 97(5): 335-42, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10709909

ABSTRACT

Immunohistochemistry was applied to AMeX-fixed tissue sections of 12 adenocarcinomas of the stomach (seven intestinal adenocarcinomas and five diffuse carcinomas), 12 adenocarcinomas of the pancreas (nine ductal adenocarcinomas and three signet ring carcinomas), and 12 squamous cell carcinomas of the larynx obtained at surgical resection to examine the possibility of extravascular activation of blood coagulation in cancer tissues by exploring the in loco patterns of distribution of fibrinogen, a final product of blood coagulation, fibrin, and a by-product of coagulation reactions (prothrombin fragment 1+2). Gastric, pancreatic, and laryngeal cancers exhibited fibrinogen antigen in abundance throughout the tumor stroma. Fibrin was detected along the edges of nests of carcinoma cells and at the host-tumor interface. Prothrombin fragment 1+2 was present in the blood vessels in areas of neoangiogenesis at the host-tumor interface (gastric and pancreatic cancer tissues) and on the tumor cell bodies (pancreatic and laryngeal cancer tissues). The presence of prothrombin fragment 1+2 in cancer tissues appears to be a good indicator of coagulation activation and thrombin generation at the tumor burden.


Subject(s)
Adenocarcinoma/chemistry , Biomarkers/blood , Carcinoma, Squamous Cell/chemistry , Gastrointestinal Neoplasms/chemistry , Peptide Fragments/biosynthesis , Prothrombin/biosynthesis , Adenocarcinoma/blood supply , Adenocarcinoma/complications , Blood Coagulation , Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/complications , Fibrin/biosynthesis , Gastrointestinal Neoplasms/blood supply , Gastrointestinal Neoplasms/complications , Immunohistochemistry , Laryngeal Neoplasms/blood , Laryngeal Neoplasms/chemistry , Laryngeal Neoplasms/complications , Neovascularization, Pathologic , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/chemistry , Pancreatic Neoplasms/complications , Stomach Neoplasms/blood , Stomach Neoplasms/chemistry , Stomach Neoplasms/complications , Stromal Cells/pathology
12.
Thromb Haemost ; 82(6): 1659-62, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10613652

ABSTRACT

The blood coagulation mechanism may support tumor progression by several mechanisms including promotion of cell proliferation and angiogenesis. Immunohistochemical procedures were applied to AMeX-fixed sections of twelve cases of squamous cell carcinoma of the larynx obtained at surgical resection to determine the presence and distribution of tissue factor (TF), tissue factor pathway inhibitor (TFPI), other coagulation factors, fibrinogen, and fibrin in situ. TF antigen was present in normal squamous epithelial cells and tumor cells, predominantly in immature tumor cells in the vicinity of the host-tumor interface. Tumor cells stained also for factors VII and X. Staining for TFPI antigen was demonstrated in the connective tissue stroma adjacent to the tumor, in microvascular endothelial cells, and in normal squamous epithelial cells. Fibrinogen and factor XIIIa were distributed throughout the tumor connective tissue stroma. Fibrin (thrombin-cleaved fibrinogen) was detected at the host-tumor interface and along the margins of tumor nodules. Tumor cells in carcinoma of the larynx express a functional, TF-initiated pathway of blood coagulation. Interpretation of these findings together with the results of clinical trials of inhibitors of TF-induced coagulation activation versus effects of inhibitors of TF expression suggest novel approaches to the experimental therapy of laryngeal carcinoma.


Subject(s)
Carcinoma/metabolism , Laryngeal Neoplasms/metabolism , Lipoproteins/biosynthesis , Thromboplastin/biosynthesis , Blood Coagulation , Carcinoma/blood supply , Humans , Laryngeal Neoplasms/blood supply , Neovascularization, Pathologic
13.
Neurol Neurochir Pol ; 33(3): 685-91, 1999.
Article in Polish | MEDLINE | ID: mdl-10540728

ABSTRACT

The authors report a case of Creutzfeldt-Jakob disease in a man aged 60 years from a family without a history of similar disease. The disease extended over 11 months. In the clinical picture initially equilibrium disturbances and dementia with psychotic symptoms predominated, EEG pattern was not typical of CJD. Neuropathological examination revealed extensive spongiform lesions in the cortex of all cerebral lobes, in striatum and substantia nigra, moreover a considerable number of kuru plaques was found in cerebellar cortex. The authors consider that the case meets the criteria accepted for the sporadic form of CJD but believe that the final differentiation from the Gerstmann-Streussler-Scheinker syndrome should be based on genetic studies.


Subject(s)
Occipital Lobe/pathology , Cerebellum/pathology , Diagnosis, Differential , Electroencephalography , Electromyography , Extremities/physiopathology , Fatal Outcome , Humans , Magnetic Resonance Imaging , Male , Middle Aged
14.
Neurol Neurochir Pol ; 33(1): 87-96, 1999.
Article in Polish | MEDLINE | ID: mdl-10399728

ABSTRACT

The aim of the study including 89 brain gliomas was to determine their proliferative activity assayed with immunohistochemical methods (PCNA and Ki-67) and with the method of AgNORs, as well as to evaluate the correlation between the proliferative activity and features of histological malignancy. The study reveals that the estimation of PCNA, Ki-67 and AgNORs are effective methods for the determination of the proliferative activity of brain gliomas. Statistically significant differences were noted in the proliferative PCNA, Ki-67 and AgNORs between groups of gliomas with lower and higher malignancy, which indicated a distinct correlation between histological malignancy of the tumours and their proliferative activity. High values of PCNA and Ki-67 (> 40%) and AgNORs (> 15) were found to considerably deteriorate prognosis in brain gliomas.


Subject(s)
Astrocytoma/pathology , Brain Neoplasms/pathology , Cell Movement/physiology , Glioblastoma/pathology , Neuroglia/cytology , Proliferating Cell Nuclear Antigen/physiology , Adult , Antibodies, Monoclonal , Astrocytoma/surgery , Brain Neoplasms/surgery , Child , Female , Glioblastoma/surgery , Humans , Male , Middle Aged , Prognosis , Retrospective Studies
16.
Neurol Neurochir Pol ; 32(4): 877-83, 1998.
Article in Polish | MEDLINE | ID: mdl-9864716

ABSTRACT

The aim of the study of 41 multiform glioblastomas was the analysis of p53-protein immunoreactivity in neoplastic cells and evaluation of relationship of this biologic marker to tumour proliferation activity. Positive p53 expression was observed in 24 (58.5%) tumours, the negative one in 17 tumours (41.5%). Proliferation indexes of PCNA, anti-Ki6 and AgNORs showed high values in the multiform glioblastoma p53 positive group, but without statistical differences in comparison with the group of p53-negative glioblastomas. Significant differences were observed in survival time of patients with p53 positive tumours in comparison with p53-negative ones. In 15 patients with p53-positive multiform glioblastomas survival time was less than 6 months (62.5%) on the contrary with only 4 patients with similar survival time in p53-negative glioblastoma group (23.5%). Our results suggest that p53 expression in multiform glioblastoma cells, generally considered as the indirect index of p53 suppressor gene, reflects aggressive stadium of neoplastic disease and significantly worsens the prognosis.


Subject(s)
Cell Movement/genetics , Glioblastoma/genetics , Tumor Suppressor Protein p53/genetics , Adult , Antibodies, Monoclonal/immunology , Cell Transformation, Neoplastic/genetics , Female , Glioblastoma/immunology , Glioblastoma/mortality , Humans , Male , Middle Aged , Retrospective Studies , Survival Rate
17.
Hepatogastroenterology ; 45(22): 1130-4, 1998.
Article in English | MEDLINE | ID: mdl-9756019

ABSTRACT

BACKGROUND/AIMS: Argyrophilic nucleolar organizer regions (AgNORs) reflect the proliferative activity of cells. Since the majority of pancreatic cancers are ductal carcinomas, the aim of the study was to determine the AgNORs expression of potential pre-neoplastic ductal epithelial lesions in advanced chronic pancreatitis compared with pancreatic cancer cells. METHODOLOGY: Histological preparations obtained from 24 patients with chronic pancreatitis and 16 patients with pancreatic cancer were used to estimate the number of AgNORs per nucleus. Four types of AgNORs were distinguished and histograms with cell percentage of each type were performed for all forms of epithelial anomalies. RESULTS: In simple hyperplasia, squamous and mucous metaplasia the number of AgNORs ranged from 1.92 to 2.23; type I was predominant. In papillary hyperplasia, dysplasia and in situ carcinoma the number ranged from 2.98 to 3.34, with a predominance of type II-IV. In invasive carcinoma the number was 4.29 and 74% of cells were of type II-IV. CONCLUSIONS: Both counts of AgNORs and the percentage of type II-IV cells showed a gradual increase from simple hyperplasia through papillary hyperplasia and dysplasia to invasive carcinoma which in this respect differs significantly from all forms of the epithelial anomalies examined.


Subject(s)
Nucleolus Organizer Region/metabolism , Pancreatic Ducts/metabolism , Pancreatic Neoplasms/metabolism , Pancreatitis/metabolism , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Cell Division , Chronic Disease , Histocytochemistry , Humans , Hyperplasia/metabolism , Hyperplasia/pathology , Pancreatic Ducts/pathology , Pancreatic Neoplasms/pathology , Pancreatitis/pathology , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Silver Staining
18.
Postepy Hig Med Dosw ; 52(6): 577-90, 1998.
Article in Polish | MEDLINE | ID: mdl-10093477

ABSTRACT

Solid tumors are dependent on angiogenesis for sustained growth, therefore anti-angiogenic treatment is a potential antineoplastic therapy. Glioblastoma multiforme has been considered a suitable candidate for such treatment. This review summarizes the fundamentals of angiogenic process in glioblastoma multiforme and in other types of brain tumors for which they represent a potential for anti-angiogenic therapy.


Subject(s)
Brain Neoplasms/pathology , Neovascularization, Pathologic/pathology , Animals , Brain Neoplasms/physiopathology , Brain Neoplasms/therapy , Glioblastoma/pathology , Glioblastoma/therapy , Humans , Neovascularization, Pathologic/physiopathology
19.
Pol Merkur Lekarski ; 5(26): 63-5, 1998 Aug.
Article in Polish | MEDLINE | ID: mdl-10101456

ABSTRACT

Thromboembolic events may complicate clinical course of chronic pancreatitis. It is accepted that trypsin plays a role in the pathogenesis of these abnormalities. However there is a lack of information about local activation of blood coagulation in pancreatic tissue in chronic inflammation and contribution of tissue factor (TF) to this process. Immunohistochemistry was applied to AMeX-fixed sections of tissues of ten cases of chronic pancreatitis to explore the presence and distribution of components of the coagulation system in situ. TF antigen was present in cells of ductules. Fibrinogen and fibrin were detected in the inflammatory infiltrates of the pancreatic tissue. The data suggest that there is local activation of blood coagulation in pancreatic tissue in chronic inflammation that depends on tissue factor.


Subject(s)
Blood Coagulation/physiology , Pancreatitis/blood , Pancreatitis/pathology , Antibodies, Monoclonal/metabolism , Chronic Disease , Fibrinogen/metabolism , Humans , Immunohistochemistry , Pancreatitis/metabolism , Thromboplastin/metabolism , Whole Blood Coagulation Time
20.
Neurol Neurochir Pol ; 31(1): 89-101, 1997.
Article in Polish | MEDLINE | ID: mdl-9235522

ABSTRACT

Chordoma is one of rare intracranial neoplasms (0.2-0.5%). Apart from classic chordoma in 1973 r. Heffelfinger and al. separated chondroid chordoma which showed better prognosis. We studied 4 classic and 3 chondroid intracranial chordomas. All tumours contained chondroitine sulfate and keratan sulfate and showed positive immunohistochemical reactions to cytokeratin, S-100 protein and vimentin, supporting the concept of common origin of both types of chordomas. Immunohistochemical studies of PCNA and Ki-67 antigen and staining AgNOR's did not show significant differences in the proliferative activity between both types chordomas what attests to biological malignancy.


Subject(s)
Biomarkers, Tumor/analysis , Brain Neoplasms/pathology , Chordoma/parasitology , Adult , Chondroitin Sulfates/analysis , Female , Humans , Immunohistochemistry , Keratan Sulfate/analysis , Keratins/analysis , Ki-67 Antigen/analysis , Male , Middle Aged , Proliferating Cell Nuclear Antigen/analysis , S100 Proteins/analysis , Vimentin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...